肝素

川芎嗪组远期通畅率与肝素组相比，无明显差异（P＞0.05）。

There were no difference between group ligustrazine and group heparin ( P > 0.05 ) .

可生物降解肝素钠/两性壳聚糖复合物用于蛋白药物pH响应释放研究

Biodegradable heparin / ampholytic chitosan complexes for pH-sensitive release of proteins

扩增小片段时，肝素钠对PCR的扩增效率影响较小。

Heparin sodium inhibited amplification efficiency slightly while small size fragment was amplified .

低分子肝素治疗非ST段抬高急性冠状动脉综合征的疗效

The efficacy observation of low-molecular weight heparins therapy for acute coronary syndrome with non-ST-segment elevation

肝素表面处理的PMMA人工晶体的临床分析

Clinical analysis of intraocular PMMA lenses modified with surface immobilized heparin

NSCLC中肝素酶与端粒酶活性表达无相关性（P0.05）。

There was no correlation between heparinase mRNA expression and telomerase expression in NSCLC .

本文报告38例先天性心脏病患儿应用活化凝血时间（ACT）测定，以了解小儿心内直视手术期间血液中肝素的有效浓度。

The effective concentration of heparin in the blood was monitored by activated clotting time ( ACT ) during open heart surgery in children .

目的探讨肝素酶基因及血管内皮生长因子（VEGF）在非小细胞肺癌（NSCLC）中的表达及其临床病理学意义。

Objective To study the clinicopathological significance of heparanase and VEGF expression in NSCLC .

方法122例患者PCI术后皮下注射低分子肝素60～mg，1次/12～h，共3～d。

Methods 122 patients after PCI received subcutaneous injection of 60 mg LMWH once every 12 hours for three days .

肝素对人髓性白血病细胞系K562生长的影响

The Influence of Heparin on the Growth of Human Myeloid Leukemia Cell Line K562

使用傅立叶变换红外光谱（FT-IR）、X射线光电子能谱（XPS），证明了肝素化后的材料表面化学成分的变化。

Fourier transform infrared spectroscopy and X-ray Photoelectron Spectroscopy were used to illustrate the composition changes of PLGA .

那屈肝素钙在ACS治疗上是否比其他低分子量肝素有优势？

Does Nadroparin Calcium have any advantage in ACS treatment over other LMWHs ?

肝素钙治疗IgA肾病临床分析

Therapeutic effects of Hepacarin in IgA Nephropathy

低分子肝素对难治性肾病综合征患者血浆PAI-1的影响

Influence of low-molecular-weight heparin on PAI-1 in refractory nephritic syndrome patients

微剂量肝素治疗急性白血病前DIC临床观察

Research of micro-dose heparin therapy for acute leukemia with pre-diffuse intravascular coagulation

目的评价非全身肝素化状态下冠状动脉造影（CAG）的安全性。

Objective To evaluate the safety of coronary angiography ( CAG ) without heparinization .

微量肝素预防外科DIC的临床研究

Clinical study with microdosage heparin in preventing surgical DIC

应用小剂量肝素预防肝静脉闭塞病（VOD）。

The prognosis of hepatic veno-occlusive disease ( VOD ) was used by low dose heparin .

肝素可增强bFGF促进创面肉芽组织生长、毛细血管增生、纤维母细胞增殖及细胞DNA合成。

Heparin could enhance activity of bFGF to stimulate formation of granulation tissue , regeneration of capillary , proliferation of fibroblast and DNA synthesis .

低分子量肝素预防ERCP术后急性胰腺炎的临床研究

Clinical study on the prevention of acute pancreatitis after ERCP with low molecular weight heparin

山羊精子在mDM液中38.5℃、肝素浓度为50μg／ml、获能45分钟获能效果最好。

Goat spermatozoa were best capacitated when incubated in mDM supplemented with 50 μ g / ml heparin at 38.5 ℃ for 45 min.

所有患者均接受静脉注射普通肝素及口服二磷酸腺酐（ADP）受体拮抗剂和阿司匹林。

All patients received intravenous heparin and oral ADP receptor antagonist and aspirin .

肝素对过敏性紫癜患儿血清中IL-6、IL-8水平有影响，能降低其水平。

The study showed that early heparin therapy could decrease the serum levels of IL-6 , IL-8 in HSP patients .

方法对28例伴有高危出血的维持性血液透析患者随机分为A、B两组，均给予无肝素血液透析。

Methods : 28 patients with high risk hemorrhage in need of sustained hemodialysis were divided into two groups ( A and B ) randomly , all patients were administrated hemodialysis without heparin .

肝素酶mRNA表达率在不同性别、年龄组比较，差异无显著性（P>0.05）。

The enzyme mRNA expressing rate of heparin is compared in different sex , age group , the difference has no significance ( P > 0.05 ) .

MK是肝素结合因子家族中的一个成员。

MK is a member of heparin binding growth factor family .

测定硫酸软骨素A，硫酸软骨素C及硫酸肝素对DPC粘附及生长的影响。

Influence was examined on the adhesion and growth of dermal papilla cells by chondroitin sulfate A , chondroitin sulfate C and heparin sulfate .

术后根据凝血酶原时间（PT），使用普通肝素或低分子肝素预防性抗凝。

Regular heparin or low-molecular-weight heparin as a prophylactic anticoagulation therapy was maintained during and after ( operation ) as indicated by prothrombin time .

低分子肝素（lowmolecularweightheparin，LMWH）是未分级肝素经化学或酶法解聚而得，相对分子质量为4000～6500。

Low molecular weight heparin ( LMWH ) was obtained by chemical or enzymatic digestion of heparin . Its relative molecular weight was from 4000 Dalton to 6500 Dalton .

目的研究低分子肝素对人肝癌裸鼠模型（LCI-D20）中环氧合酶-2（COX-2）表达的影响。

[ Objective ] To study effects of low molecular weight heparins on cyclooxygenase-2 ( COX-2 ) of hepatocarcinoma in vivo .